Collaboration Agreements
All Business Industries
Mersana Therapeutics, Inc. (69) | Collaboration Agreements (6)
- Amendment 3 to the Collaboration and Commercial License Agreement, dated February 28, 2017, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
- Amendment 2 to the Collaboration and Commercial License Agreement, dated August 12, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
- Amendment 1 to the Collaboration and Commercial License Agreement, dated June 1, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
- Collaboration and Commercial License Agreement, dated June 23, 2014, by and between Mersana Therapeutics, Inc. and Merck KGaA (Filed With SEC on May 9, 2023)
- Collaboration and Commercial License Agreement, dated December 22, 2022, between Mersana Therapeutics, Inc. and Ares Trading S.A (Filed With SEC on February 28, 2023)
- Research Collaboration and License Agreement, dated February 2, 2022, between the Company and Janssen Biotech, Inc (Filed With SEC on May 9, 2022)